Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a241ad4b9b81612b

Jump to content

Talk:Heliyon

Page contents not supported in other languages.
Add topic
From Wikipedia, the free encyclopedia
Latest comment: 1 year ago by Randykitty in topic reply to Randykitty's deletions

reply to Randykitty's deletions

[edit]

Hi, Randykitty: it is always fun to bump into you. I usually agree with and thank you for some your reversals, but not with the two about Heliyon. 1) Who owns Scopus is important here, because both Scopus and Heliyon are owned by Elsevier, and the latter has been accused of unfair promotion of its journals: https://en.wikipedia.org/w/index.php?title=Elsevier&action=edit&section=17 . I feel, that instead of deleting the infor about Elsevier ownership, it should be expanded to mention the unfair promotion, such as Manipulation of bibliometrics. 2) mentioning the OA publishing cost is important here, because it is fairly high compared to other OA mega-journals, and because such high OA price motivates the Publishers to accept every manuscript, including those that resulted in Heliyon "delisting" by the Web of Science. Again, I feel that this topic should be expanded rather than deleted. If I do not hear back from you within the next few days, I will proceed with the proposed expansion.  Preceding unsigned comment added by Walter Tau (talkcontribs)

  • Hi. 1/ Scopus: Whatever one may think of Elsevier, they're not stupid. Scopus must be a major investment for them. If ever someone would decisively show that Elsevier journals would get preferential treatment on Scopus, or, worse, would get artificially inflated scores, nobody would subscribe to Scopus any more and their investment would be lost. As far as I know, nobody has ever shown that Elsevier abuses Scopus. Also, there's UNDUE and SYNTH to consider. We have thousands of journal articles linking to Scopus, obviously it would not be correct to put this disclaimer in each of these articles, especially if there's no proof of anything untoward. 2/ As for the cost of OA publishing, WP is not a catalogue. Also, like the Scopus remark above, why putting that in this article and not in all other OA journal articles? And if we would ignore all that, just imagine the effort that would be needed to keep all those prices current. Finally, concerning that delisting of Heliyon by Clarivate, at this point it's pure speculation why it was delisted. (and to be a bit pedantic, strictly speaking Heliyon is not delisted but "on hold" during a re-evaluation, which is currently being carried out.) --Randykitty (talk) 17:35, 11 October 2024 (UTC)Reply